Table 1 Training, validation and test cohorts for SOM and LVQ analyses.
Cohort | Tumor class non-sarcomatoid | Tumor volume, cm3 | Tumor class sarcomatoid | Tumor volume, cm3 | |
|---|---|---|---|---|---|
SOM Phase | LVQ Phase | ||||
Training | Training | Clear cell RCC | 15.4 | Clear cell RCC | 13.7 |
Clear cell RCC | 55.6 | Clear cell RCC | 106.6 | ||
Clear cell RCC | 196.6 | Clear cell RCC | 187.9 | ||
Clear cell RCC | 306.4 | Clear cell RCC | 305.9 | ||
Clear cell RCC | 501.8 | Chromophobe RCC | 459.7 | ||
Clear cell RCC | 610.8 | Clear cell RCC | 611.0 | ||
Clear cell RCC | 1135.0 | Clear cell RCC | 731.1 | ||
Clear cell RCC | 1425.0 | Clear cell RCC | 953.5 | ||
Not used | Validation | Clear cell RCC | 410.3 | Clear cell RCC | 442.9 |
Clear cell RCC | 683.8 | Clear cell RCC | 866.4 | ||
Clear cell RCC | 1184.7 | Papillary RCC | 1440.7 | ||
Not used | Testing | Clear cell RCC | 175.2 | Clear cell RCC | 182.0 |
Clear cell RCC | 263.3 | Clear cell RCC | 269.3 | ||
Clear cell RCC | 380.6 | Clear cell RCC | 372.6 | ||
Clear cell RCC | 509.0 | Chromophobe RCC | 490.9 | ||
Clear cell RCC | 1258.8 | Clear cell RCC | 1291.1 | ||
